Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK(TM) Cell Engager antibody at EHA 2022 Congress

Stock Information for GTY Technology Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About GTY Technology Holdings Inc.

Supernatural New Adult Thriller Combines Dark Family Secrets, A Mysterious Island, And Dark Fantasy Elements Into A Can't-Miss Read
Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution
ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT
Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK(TM) Cell Engager at EHA 2022 Congress
Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, CLBS, ISLE, AOGO
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Blueknight Energy Partners, L.P. (Nasdaq - BKEP), PS Business Parks Inc. (NYSE - PSB), Isleworth Healthcare Acquisition Corp. (Nasdaq - ISLE), Arogo Capital Acquisiti
Isleworth Healthcare Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.